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Epidemiologic studies demonstrated that long-term exposure to arsenic induces arsenical skin cancers, including
Bowen’s disease. Immunohistochemically, Bowen’s disease shows proliferating and apoptotic characteristics. The
transcription factors nuclear factor-jB (NF-jB) and activator protein-1 (AP-1) functionally regulate cell proliferation,
transformation, and apoptosis. To investigate the mechanism of arsenic-induced apoptosis and related alterations
in NF-jB and AP-1 activity, we exposed cultured human foreskin keratinocytes to different concentrations of
sodium arsenite. At lower concentrations (p1 lM), arsenic induced keratinocyte proliferation and enhanced both
NF-jB and AP-1 activity. At higher concentrations (X5 lM), arsenic induced keratinocyte apoptosis by the Fas/Fas
ligand (FasL) pathway. At apoptosis induction concentrations, NF-jB activity was not enhanced; however, AP-1
activity was further enhanced. These results indicated that upregulation of NF-jB at lower arsenic concentrations
was correlated with keratinocyte proliferation. In contrast, higher concentrations of arsenic enhanced AP-1 and
induced Fas/FasL-associated apoptosis. The concentration-dependent arsenic effects on transcription factors
activity can help to clarify the mechanisms in arsenic-induced proliferation and apoptosis in keratinocytes.
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Long-term exposure to inorganic arsenic through ingestion
and inhalation is associated with an increased risk of
malignant tumors development in many organs, such as the
lung, stomach, liver, colon, kidney, and urinary bladder in
addition to skin cancers (Chen et al, 1985). Arsenite is
considered to be the most likely carcinogenic form of
arsenic (Rossman, 1998). The most common arsenical skin
cancer is Bowen’s disease, which is a carcinoma in situ of
the skin. Microscopically, abnormal proliferation, apoptosis,
and dysplasia are observed in Bowen’s disease (Yu et al,
2001). In vitro studies indicate that arsenic can induce
biphasic effects on cultured human keratinocytes. At low
concentrations, arsenic was reported to decrease the
expression of DNA repair genes and increase the expres-
sion of oxidative stress responding genes and cell-
proliferation-related genes in keratinocytes (Hamadeh et al,
2002). Arsenic can enhance growth-promoting cytokines
such as granulocyte-macrophage colony-stimulating factor,
transforming growth factor-a, and interleukin-8 (Yen et al,
1996; Germolec et al, 1998). Nevertheless, growth inhibition
and cell death are observed at higher concentrations of
arsenic in a variety of cell systems (Park et al, 2000; Roboz
et al, 2000; Yu et al, 2002). Cellular events of arsenic-induced
proliferation, comutagenesis, and apoptosis are reported to
associate with regulations of transcription factors, such as
nuclear factor-kB (NF-kB) and activator protein-1 (AP-1)
(Cavigelli et al, 1996; Huang et al, 2001; Wijeweera et al,
2001; Dong, 2002). The purpose of this study was to
investigate arsenic-induced apoptosis and arsenic related
alterations in NF-kB and AP-1 activity. We found that low
concentrations of arsenic enhanced keratinocyte prolifera-
tion, which is correlated with increased NF-kB activity. High
concentrations of arsenic induced keratinocyte apoptosis by
Fas/Fas ligand (FasL) signaling, which is correlated with
decreased NF-kB activity and enhanced AP-1 activity.
Results
Effects of arsenic on keratinocyte viability As shown in
Fig 1, no significant change in cell viability was observed
when keratinocytes were treated with low concentrations
(0.01–1 mM) of arsenic for 24 h. Enhanced cell viability was
Abbreviations: AP-1, activator protein-1; DISC, death-
inducing signaling complex; FADD, Fas-associated death
domain protein; FasL, Fas ligand; NF-kB, nuclear factor
kappa-B; PARP, poly(ADP-ribose)polymerase; PBS, phos-
phate-buffered saline; TRAIL, TNF-related apoptosis-indu-
cing ligand.
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observed at 48 and 72 h with 1 mM arsenic treatment, about
18 and 32% cell viability increase was noticed, respectively.
Nevertheless, cell viability decreased when arsenic con-
centrations were higher than 1 mM. An approximately 50
and 60% decrease in cell viability was noticed at 5 mM
arsenic treatment in 48- and 72-h incubation, respectively.
At 48 and 72 h of incubation, arsenic treatment revealed a
similar pattern in cell viability. Therefore, in this study we
chose 0, 0.1, 1, 5, and 10 mM arsenic doses and a 48-h
incubation period for further investigations.
High arsenic concentrations induced keratinocyte apop-
tosis by Fas/FasL-associated signaling Typical features
of apoptotic DNA ladders were observed at 5 and 10 mM
arsenic-treated groups (Fig 2A). To confirm the pathway
involved in arsenic-induced apoptosis, expression of Fas
and FasL was detected. As shown in Table I one mM of
arsenic increased FasL expression. Higher concentrations
of arsenic (5 and 10 mM) enhanced both Fas and FasL
expression on keratinocytes. zVAD-fmk was used to inhibit
caspase and avoid apoptosis in cells. The results in Table I
indicated that zVAD-fmk did not affect arsenic-induced Fas/
FasL expression on keratinocytes. To further confirm the
regulatory activity of Fas pathway, Fas-associated apopto-
tic factors and caspases were detected. Expression of
FADD, activated caspase-8, and caspase-3 was enhanced
by 5 and 10 mM arsenic (Fig 2B). PARP is a substrate for
activated caspase-3. In 5 and 10 mM arsenic-treated
groups, an 85-kDa fragment of cleaved PARP was observed
(Fig 2B).
Fas/FasL and caspase inhibition tests Fas-neutralizing
antibody, FasL-neutralizing antibody, and zVAD-fmk cas-
pase inhibitor were used to confirm the involvement of Fas-
associated pathway in arsenic-induced apoptosis. As
shown in Fig 3, Fas, FasL antibody, and zVAD-fmk
efficiently reduced arsenic-induced cell death. The inhibi-
tory efficiency of Fas and FasL-neutralizing antibody was
similar. The inhibitory effect of zVAD-fmk was significantly
higher than that of Fas or FasL-neutralizing antibody. Anti-
Fas-neutralizing antibody inhibited 31% of cell death by 5
mM arsenic and 15% by 10 mM arsenic. zVAD-fmk was able
to inhibit 40 and 29% of cell death induced by 5 and 10 mM
arsenic, respectively.
Effects of arsenic on NF-jB and AP-1 activity As shown
in Fig 4, the activity of NF-kB was enhanced by lower
concentrations of arsenic. NF-kB activity increased to
the maximum level in the 1 mM arsenic-treated group.
Figure 1
Effects of arsenic on keratinocyte viability. Keratinocytes were
treated with different concentrations of sodium arsenite and incubated
in a CO2 incubator at 371C for 24 to 72 h. The cell viability was analyzed
by XTT assay. Viability of the control group (no arsenic added; PBS
only) was taken as 100% (mean  SD; n¼12).
Figure2
Arsenic induced apoptosis and enhanced expression of Fas-
associated apoptotic proteins. (A) Cultured keratinocytes were
exposed to 1, 5, or 10 mM arsenic for 48 h. Cellular DNA was isolated
and performed by 2% agarose gel electrophoresis. The 180-bp DNA
ladders were observed as a typical feature for apoptosis (M, 100-bp
DNA marker; C, control). (B) Fas-associated apoptotic proteins were
detected by Western blotting. Total cellular protein was isolated from 48
h arsenic-treated keratinocytes. FADD, caspase-8 (p18, active form),
caspase-3 (p20, active form), and PARP antibodies were used. PARP
antibody can react with the 112-kDa PARP and its 85-kDa fragment
specifically cleaved by activated caspase-3.
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Nevertheless, no further increase in NF-kB activity was
observed in the 5 and 10 mM groups. In contrast, activity of
AP-1 was enhanced by arsenic in a concentration-dependent
manner. These results were confirmed by the analysis of the
changes in NF-kB and AP-1 protein levels (data not shown).
Discussion
Lesions of arsenic-induced Bowen’s disease reveal histo-
pathologic evidences of abnormal proliferation and apop-
tosis (Yu et al, 2001). Although proliferation and apoptosis
were not induced concurrently in a single arsenic treatment,
the differential expressions of transcription factors at low
and high doses of arsenic provide a model for how arsenic
may act. NF-kB regulates multiple and complex gene
expression associated with both cell proliferation and
death. Several keratinocyte-proliferation-associated factors
are regulated by NF-kB, such as interleukin-8 (Mukaida et
al, 1990; Tuschil et al, 1992; Chabot-Fletcher and Breton,
1998). NF-kB was reported to provide survival signals that
prevent cells from apoptosis by Fas and TNF-receptor-
initiated apoptotic signals (Beg and Baltimore, 1996; Liu et
al, 1996). In this study, NF-kB activity was enhanced by low
concentrations of arsenic and linked to keratinocyte
proliferation. In contrast, the activity of NF-kB was not
enhanced at high arsenic concentrations, and apoptosis
was induced. These results suggest that the change of
NF-kB activity is related to arsenic-induced keratinocyte
proliferation and death.
Fas/FasL pathway is important in regulating keratinocyte
apoptosis (Leverkus et al, 1997). Activation of Fas results in
the association of FADD to form a death-inducing signaling
complex (DISC) and further activates the caspase cascade
(Wallach et al, 1999; Leverkus et al, 2003). Briefly, Fas-
associated caspase cascade is initiated by activation of
caspase-8, which in turn induces activation of caspase-3,
which cleaves PARP and induces apoptotic cell death
(Muzio et al, 1996). In this study, both Fas and FasL
expression was enhanced by 5 and 10 mM arsenic, and
apoptosis was induced. Intracellular FasL is constitutively
expressed in normal keratinocytes and lacks apoptosis
Table I. Flow cytometric analysis of Fas and FasL expression on keratinocytesa
MFI
Fas FasL
Arsenic treatment (lM) Without zVAD With zVAD Without zVAD With zVAD
0 53.2  4.7 55.3  7.6 27.4  5.5 24.3  3.5
0.1 53.8  7.5 52.3  7.8 31.3  4.6 22.6  4.2
1 51.9  6.1 57.2  6.2 40.8  6.7b 46.2  5.4b
5 74.7  8.3b 69.5  7.1b 91.6  6.0b 86.7  7.3b
10 80.5  5.8b 82.4  4.3b 103.2  10.4b 98.4  7.1b
aAfter a 48-h incubation with 0.1 to 10 mM arsenic with or without zVAD-fmk, mean fluorescent intensity (MFI) of Fas and FasL were analyzed by flow
cytometry.
bpo0.05, treated group versus nontreated group by Student’s t test; mean  SD; n¼ 12.
Figure 3
Fas neutralization and caspase inhibition assay. Arsenic-exposed
keratinocytes were treated with anti-Fas-neutralizing antibody, anti-
FasL-neutralizing antibody, or zVAD-fmk. After 48 h of treatment, cell
viability was measured by XTT assay. Results were analyzed by one-
way ANOVA (po0.05, treated group vs. nontreated group; #po0.05,
anti-Fas or anti-FasL antibody-treated group vs. zVAD-fmk-treated
group; mean  SD; n¼12).
Figure4
Arsenic-altered NF-jB and AP-1 activity. Keratinocytes were
exposed to 0.1, 1, 5, and 10 mM of arsenic for 48 h. Activity of NF-kB
and AP-1 was detected by pNFkB-TA-Luc and pAP1-Luc luciferase
activity assay, respectively. The luciferase activity was normalized with
renilla luciferase activity (po0.05, treated group vs. nontreated group
by Student’s t test; mean  SD; n¼ 12).
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inducing ability. The apoptosis-inducing ability of FasL is
activated when translocated onto the surface of cell
membrane by intermediate filaments related regulation
(Viard-Leveugle et al, 2003). By propidium iodide exclusion,
we ascertain that the detected Fas and FasL are at the cell
surface of keratinocytes. This result implies that arsenic
may also modulates translocation of FasL. Arsenic-induced
Fas and FasL expression was not affected by zVAD-fmk
caspase inhibitor, suggesting that arsenic-induced Fas/
FasL is regulated upstream of the activation of caspases or
the DISC. Increased Fas-downstream proteins, that is,
FADD, activated caspase-8, caspase-3, and PARP clea-
vage, indicate that the Fas/FasL pathway is activated by
high concentrations of arsenic. Furthermore, Fas and FasL-
neutralizing antibody, as well as zVAD-fmk, significantly
reduced arsenic-induced cell death. These results further
confirmed the involvement of Fas/FasL-associated pathway
in arsenic-induced keratinocyte apoptosis. Arsenic is
believed to disturb protein functions by reacting with
exposed sulfhydryl groups (Snow, 1992). Arsenic reacts
with the sulfhydryl group on JNK phosphatase, which
causes an irreversible JNK activity and sustained AP-1
activation (Cavigelli et al, 1996). A concentration-dependent
activation of AP-1, as well as increased phosphorylated
c-Jun (data not shown), was observed in this study.
Because promoter regions of FasL and TNF-a contain
binding sites for AP-1, activation of AP-1 can promote
apoptosis by Fas/FasL or TNF receptor/TNF-a signaling
(Faris et al, 1998; Zagariya et al, 1998; Kolbus et al, 2000).
Arsenic stimulates TNF-a release from T cells and induces
CD4þ T cells apoptosis via TNF receptor-1 signaling (Yu et
al, 2002). Arsenic could induce TNF-a release from
keratinocytes; however, TNF receptor-1 expression and
TNF receptor-1-associated apoptosis were not enhanced
(data not shown). Our results indicate that AP-1 is related to
upregulation of FasL and Fas/FasL pathway contributes to
arsenic-induced apoptosis in keratinocytes.
Fas/FasL-neutralizing antibodies and zVAD-fmk caspase
inhibitor efficiently inhibited arsenic-induced keratinocyte
apoptosis, but the apoptotic process was not completely
blocked. Furthermore, inhibitory effect of zVAD-fmk was
higher than Fas or FasL-neutralizing antibody. These
findings indicate that other pathways may be involved in
arsenic-induced keratinocyte death. TNF-related apopto-
sis-inducing ligand (TRAIL) receptors (TRAIL receptor 1 and
2) are constitutively expressed in normal keratinocytes
(Leverkus et al, 2000). Because TRAIL receptor- and Fas-
associated apoptotic signals are initiated by FADD and their
downstream caspases at the DISC, TRAIL receptor path-
way may also contribute to arsenic-induced apoptosis. In
this study, non-arsenic-treated keratinocytes contain de-
tectable amounts of FADD, which implies that a functional
DISC may be formed in normal keratinocytes. At 1 mM
arsenic-treated group, increased FasL (but not Fas), FADD,
and activated caspase-8 were detected. Nevertheless,
activated caspase-3 and PARP cleavage were not de-
tected. It has been reported that primary keratinocytes are
more resistant to TRAIL-induced apoptosis than trans-
formed keratinocytes (Leverkus et al, 2000). This TRAIL
resistance can be abolished by proteasome inhibition
(Leverkus et al, 2003). In this study, keratinocyte apoptosis
was not induced at low arsenic concentration (1 mM), which
may be related to antiapoptosis signals of NF-kB (Liu et al,
1996) or the nature of keratinocytes which resist apoptosis.
At high concentrations, arsenic induces apoptosis by Fas/
FasL associated pathway; moreover, it is possible that
arsenic may also inhibit proteasome and make keratino-
cytes more susceptible to TRAIL-related apoptosis. Further
studies are required to delineate the regulatory mechanisms
of proteasome and TRAIL pathway in arsenic-induced
keratinocyte apoptosis.
Materials and Methods
Culture of human keratinocytes and arsenic treatment Kerati-
nocytes were obtained from adult foreskin specimens as pre-
viously described (Yu et al, 1996). Isolated keratinocytes were
cultured in commercialized keratinocyte serum-free medium
(Invitrogen, Carlsbad, CA) at 371C in a humidified incubator with
5% CO2 atmosphere. Sodium arsenite (Sigma, St. Louis, MO) was
added into the third passage of keratinocytes (final concentrations
of 0.1, 1, 5, or 10 mM except cell viability assay), and the following
experiments were performed in triplicate and approved by the
Board of Kaohsiung Medical University.
Cell viability assay The commercially available kit for cell
proliferation (XTT assay kit, Roche, Mannheim, Germany) was
used according to the manufacturer’s instruction. Keratinocytes
were treated with 0.001 to 1000 mM sodium arsenite for 24, 48, or
72 h. After treatment, XTT reagents were added into each well and
incubated at 371C for 4 h to generate colorimetric formazan
products. Absorbance of formazan product was measured at a
wavelength of 450 nm with a reference wavelength of 630 nm.
Results were expressed as relative cell viability.
DNA laddering analysis for apoptosis Keratinocytes were
collected and suspended in lysis buffer (50 mM Tris-HCl, pH 8.0,
5 mM ethylenediaminetetraacetic acid, 1.2% sodium dodecyl
sulfate, 150 mM NaCl, 0.2 mg/mL proteinase K), followed by
incubation at 371C overnight. Cellular DNA was isolated by phenol
extraction, and DNA samples were loaded into 2.0% agarose gel.
Electrophoresis was carried out in TAE buffer at 50 V for 1 h, and
the DNA was visualized by ethidium bromide staining.
Flow cytometric analysis of Fas and FasL expression Kerati-
nocytes were suspended in phosphate-buffered saline (PBS) and
incubated with 10 mg per mL propidium iodide for 30 min. After
being stained with propidium iodide, cells were incubated with
monoclonal antibody against human Fas clone DX2 or FasL clone
NOK-1 (Caltag, Burlingame, CA) in an ice bath for 30 min, followed
by incubation with FITC-conjugated anti-mouse IgG antibody for
30 min. The cells were washed three times with PBS and fixed by
4% paraformaldehyde (in PBS). Mean fluorescent intensity of Fas/
FasL was measured by a flow cytometer (ESP, Coulter, Miami, FL).
Propidium iodide-stained cells were excluded in the analysis.
Western blot analysis Polyclonal antibodies against human Fas-
associated death domain protein (FADD), caspase-8 (p18, active
form), caspase-3 (p20, active form), and poly(ADP-ribose)polymer-
ase (PARP) (Santa Cruz Biotechnology, Santa Cruz, CA) were used
in this study. Total cellular proteins isolation and protein blotting
was performed as previously described with slight modification (Yu
et al, 2002). From 20 to 100 mg of total cellular proteins was
electrophoresed on 12.5% sodium dodecyl sulfate-polyacrylamide
gel electrophoresis gels and transfer to nitrocellulose membrane.
Protein blots were visualized by using enhanced chemilumines-
cence substract kit (Pierce, Rockford, IL).
Fas, FasL, and caspase inhibition tests For Fas or FasL
blocking, the third passage of keratinocytes (2  105 cells/mL)
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was seeded into 96-well plates and incubated with 1 mg per mL
anti-Fas neutralization antibody (Clone ZB4; Upstate, Lake Placid,
NY) or anti-FasL neutralization antibody (Clone NOK-1; PharMin-
gen, San Diego, CA) for 30 min. For caspase inhibition,
keratinocytes were incubated with 200 mM zVAD-fmk (Enzyme
Systems Products, Livermore, CA) for 30 min. Arsenic was then
added without removing the neutralization antibodies or zVAD-fmk,
and the cells were cultured for 48 h at 371C. Cell viability was
measured by XTT assay.
NF-jB and AP-1 activity assay Commercially obtained vectors
designed for detecting NF-kB or AP-1 activity were used, which
contains the firefly luciferase reporter gene from Photinus pyralis.
Vector with renilla luciferase was used as internal control.
Keratinocytes grown in 24-well plates were transfected by adding
100 mL of keratinocyte serum-free medium (Invitrogen, Carlsbad,
CA) containing 1 mg of LipofectAMINE (Invitrogen, Carlsbad, CA), 4
mL of LipofectAMINE-Plus reagent, 10 ng of TK-Renilla control
vector, and 80 ng of pNFkB-TA-Luc or pAP1-Luc vector (Clontech,
Palo Alto, CA). The cells were incubated in the above mixture for 3
h at 371C. After incubation, the transfection mixture was ex-
changed to 1 mL of keratinocyte serum-free medium, and different
concentrations of arsenic were added. After 48 h of arsenic
treatment, both firefly and renilla luciferase activities were
measured using the dual-luciferase reporter assay system (Pro-
mega, Madison, WI) according to the manufacturer’s protocol.
NF-kB or AP-1 activity associated firefly luciferase activity values
were normalized with renilla luciferase activity.
Statistical analysis Statistical analyses were performed using
SPSS software. All values are presented as means  SD. The
comparison between control and test group was assessed by
unpaired Student’s t test, discriminant analysis between groups
was assessed by one-way ANOVA with Tukey’s posttest. A p value
of less than 0.05 was considered as statistically significant.
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